• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jenburkt Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4394.0
  • ISIN : INE354A01013
1,278.60 -5 (-0.42%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    1,265.00

  • Today’s High

    1,308.95

  • Open

    1,290.00

  • Perv Close

    1,284.00

  • 52W Low

    815.80

  • 52W High

    1,410.00

Key Indicators

  • P/E(TTM)

    17.93

  • Mar.Cap (₹Cr.)

    564.28

  • Div & Yield %

    1.41

  • Book Value(₹)

    389.23

  • Debt-Equity Ratio

    -0.42

  • AGM Date

    01-Aug-2025

  • EPS

    71.31

  • P/E Ratio

    17.93

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    564.28

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.41

  • BV (₹)

    389.20

  • Sales( ₹ in Cr.)

    151.69

  • NP (in Cr.)

    31.47

  • NP Var(%)

    21.0

  • Div%

    180.0

  • CPS (₹)

    77.50

  • EPS (₹)

    71.30

  • Traded Value (₹ in Lakhs)

    564.28

  • 52 Week High

    1,410.00

  • 52 Week Low

    815.80

  • Price BSE

    1279.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    564.28

  • P/C Ratio

    16.50

  • P/E Ratio

    17.90

  • Price Vs.BV

    71.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 151.69 141.97 136.75 123.98 109.29 118.89
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 151.69 141.97 136.75 123.98 109.29 118.89
Other Income 6.72 4.67 5.12 4.95 4.31 4.22
Stock Adjustments 0.12 0.39 -1.34 2.28 -3.18 0.49
Total Income 158.53 147.03 140.53 131.21 110.42 123.60
EXPENDITURE :            
Raw Materials 29.77 30.80 31.67 33.72 26.91 33.55
Power and Fuel Cost 0.71 0.75 0.76 0.61 0.50 0.59
Employee Cost 45.54 42.49 38.81 36.49 32.38 36.51
Other Manufacturing Expenses 4.30 3.58 4.28 3.85 2.50 2.98
Selling and Administration Expenses 30.27 31.04 29.03 24.32 23.03 25.46
Miscellaneous Expenses 0.83 0.58 0.50 0.01 0.95 0.54
Employee Benefit Expenses 45.54 42.49 38.81 36.49 32.38 36.51
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 111.41 109.24 105.05 99.01 86.26 99.63
Operating Profit 47.11 37.79 35.49 32.20 24.15 23.97
Interest 0.45 0.27 0.37 0.43 0.47 0.53
Gross Profit 46.66 37.52 35.12 31.77 23.68 23.44
Depreciation 2.73 2.34 2.26 1.90 2.04 2.30
Profit Before Tax 43.93 35.18 32.86 29.87 21.64 21.14
Current Tax 12.08 9.72 8.48 7.28 5.53 5.90
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.21 -0.52 -0.23 0.30 -0.39 0.37
Reported Net Profit 32.06 25.98 24.61 22.30 16.50 14.87
Extraordinary Items 0.59 0.04 0.00 0.14 0.00 0.00
Adjusted Net Profit 31.47 25.94 24.61 22.16 16.50 14.87
Adjustment below Net Profit 0.00 0.00 -14.34 0.00 0.00 -1.60
P & L Balance brought forward 134.12 113.11 108.53 90.91 74.41 69.42
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.84 4.96 5.69 4.68 0.00 8.28
P & L Balance carried down 162.34 134.12 113.10 108.53 90.91 74.41
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 180.00 153.00 144.00 120.00 102.00 81.00
Dividend Per Share(Rs) 18.00 15.30 14.40 12.00 10.20 8.10
Earnings Per Share-Unit Curr 72.65 58.86 55.76 48.58 35.96 32.40
Earnings Per Share(Adj)-Unit Curr 72.65 58.86 55.76 48.58 35.96 32.40
Book Value 389.23 328.42 277.32 255.77 214.55 174.32
Book Value(Adj)-Unit Curr 389.23 328.42 277.32 255.77 214.55 174.32

Shareholding Pattern

  • Promoter Group

    46.67%

  • Public Share Holding

    53.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 616,128 13.96 616,128 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,443,422 32.71 1,443,422 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,059,550 46.67 2,059,550 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,190 0.12 5,190 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,190 0.12 5,190 1
2] Non Institution
Bodies Corporate 142,987 3.24 142,387 48
Clearing Members 3,376 0.08 3,376 5
Directors of their Relatives 900 0.02 900 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 135,384 3.07 135,384 168
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 52,527 1.19 52,527 175
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 531,411 12.04 531,411 11
Individuals holding nominal share capital up to Rs. 1 lakh 1,380,646 31.28 1,285,946 6,290
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 101,329 2.30 101,329 2
Sub Total 2,348,560 53.22 2,253,260 6,701
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,413,300 100.00 4,318,000 6,712

Company Background

Jenburkt Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Jenburkt Pharmaceuticals Ltd
  • BSE Code : 4394.0
  • ISIN : INE354A01013

  • Incorporation Year

    1985

  • Registered Office

    Nirmala Apartment P B No 37396
    93 Jayprakash Road Andheri(W), Mumbai,
    Maharashtra-400058

  • Telephone

    91-22-66943121/67603603

  • FAX

    91-22-66943127

  • Chairman

    Ashish U Bhuta

  • Managing Director

    Ashish U Bhuta

  • Company Secretary

    Ashish R Shah

  • Auditor

    D R Mehta & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Jenburkt Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jenburkt Pharma 1,278.60 158.41 151.69 17.60 27.18
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10